The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Emerging roles of long non‐coding RNA in cancer
Open accessAbstract
Since comprehensive analysis of the mammalian genome revealed that the majority of genomic products are transcribed in long non‐coding RNA (lnc RNA), increasing attention has been paid to these transcripts. The applied next‐generation sequencing technologies have provided accumulating evidence of dysregulated lnc RNA in cancer. The implication of this finding can be seen in many forms and at multiple levels. With impacts ranging from integrating chromatin remodeling complexes to regulating transcription and post‐transcriptional processes, aberrant expression of lnc RNA may have repercussions in cell proliferation, tumor progression or metastasis. lnc RNA may act as enhancers, scaffolds or decoys by physically interacting with other RNA species or proteins, resulting in a direct impact on cell signaling cascades. Even though their functional classification is well‐established in the context of cancer, clearer characterization in terms of their phenotypic outputs is needed to optimize and identify suitable candidates that enable the development of new therapeutic strategies and the design of novel diagnostic approaches. The present article aims to outline different cancer‐associated lnc RNA according to their contribution to tumor suppression or tumor promotion based on their most current functional annotations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Li, Y., & Cheng, C. (2018) · PubMed · Cited by 57
RetractedLong non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187 · cited 1×
“projects FANTOM and ENCODE revolutionized the study of the human genome and elucidated that, in fact, 80% of the genome harbors biochemical marks of active transcription and that solely 2% of the genome is restricted to protein coding.(1,2) Thereby, the FANTOM and ENCODE platforms highlighted the pervasive way in whic…”
BackgroundThe landscape of long noncoding RNAs in the human transcriptome
Iyer, M. K., Niknafs, Y. S., Malik, R., Singhal, U., Sahu, A., Hosono, Y., Barrette, T. R., Prensner, J. R., Evans, J. R., Zhao, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3192 · Cited by 2,738
lincRNAs: Genomics, Evolution, and Mechanisms
Ulitsky, I., & Bartel, D. P. (2013) · Cell · doi:10.1016/j.cell.2013.06.020 · Cited by 2,608
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W. J., & Pandolfi, P. P. (2010) · Nature · doi:10.1038/nature09144 · Cited by 2,323
Tripathi, V., Ellis, J. D., Shen, Z., Song, D. Y., Pan, Q., Watt, A. T., Freier, S. M., Bennett, C. F., Sharma, A., Bubulya, P. A., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.08.011 · Cited by 2,219
A promoter-level mammalian expression atlas
The FANTOM Consortium and the RIKEN PMI and CLST (DGT) (2014) · Nature · doi:10.1038/nature13182 · Cited by 1,982
RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts
Geisler, S., & Coller, J. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3679 · Cited by 1,463
The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
Gutschner, T., Hämmerle, M., Eißmann, M., Hsu, J., Kim, Y., Hung, G., Revenko, A., Arun, G., Stentrup, M., Groß, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2850 · Cited by 1,415
Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins
Lee, S., Kopp, F., Chang, T.-C., Sataluri, A., Chen, B., Sivakumar, S., Yu, H., Xie, Y., & Mendell, J. T. (2016) · Cell · doi:10.1016/j.cell.2015.12.017 · Cited by 897
PVT1 dependence in cancer with MYC copy-number increase
Tseng, Y.-Y., Moriarity, B. S., Gong, W., Akiyama, R., Tiwari, A., Kawakami, H., Ronning, P., Reuland, B., Guenther, K., Beadnell, T. C., et al. (2014) · Nature · doi:10.1038/nature13311 · Cited by 722
Ultraconserved Regions Encoding ncRNAs Are Altered in Human Leukemias and Carcinomas
Calin, G. A., Liu, C.-G., Ferracin, M., Hyslop, T., Spizzo, R., Sevignani, C., Fabbri, M., Cimmino, A., Lee, E. J., Wojcik, S. E., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.027 · Cited by 719
Role of p53 in Cell Death and Human Cancers
Ozaki, T., & Nakagawara, A. (2011) · Cancers · doi:10.3390/cancers3010994 · Cited by 650
Zhang, B., Arun, G., Mao, Y. S., Lazar, Z., Hung, G., Bhattacharjee, G., Xiao, X., Booth, C. J., Wu, J., Zhang, C., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.06.003 · Cited by 598
Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss
Arun, G., Diermeier, S., Akerman, M., Chang, K.-C., Wilkinson, J. E., Hearn, S., Kim, Y., MacLeod, A. R., Krainer, A. R., Norton, L., et al. (2016) · Genes & Development · doi:10.1101/gad.270959.115 · Cited by 585
Lin, R., Maeda, S., Liu, C., Karin, M., & Edgington, T. S. (2007) · Oncogene · doi:10.1038/sj.onc.1209846 · Cited by 510
Adriaens, C., Standaert, L., Barra, J., Latil, M., Verfaillie, A., Kalev, P., Boeckx, B., Wijnhoven, P. W. G., Radaelli, E., Vermi, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4135 · Cited by 471
Dimitrova, N., Zamudio, J. R., Jong, R. M., Soukup, D., Resnick, R., Sarma, K., Ward, A. J., Raj, A., Lee, J. T., Sharp, P. A., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.025 · Cited by 445
Principles for the post-GWAS functional characterization of cancer risk loci
Freedman, M. L., Monteiro, A. N. A., Gayther, S. A., Coetzee, G. A., Risch, A., Plass, C., Casey, G., De Biasi, M., Carlson, C., Duggan, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.840 · Cited by 438
Ji, Q., Zhang, L., Liu, X., Zhou, L., Wang, W., Han, Z., Sui, H., Tang, Y., Wang, Y., Liu, N., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.383 · Cited by 381
Modulation of inflammation by autophagy: Consequences for human disease
Netea-Maier, R. T., Plantinga, T. S., van de Veerdonk, F. L., Smit, J. W., & Netea, M. G. (2016) · Autophagy · doi:10.1080/15548627.2015.1071759 · Cited by 349
GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability
Hu, W. L., Jin, L., Xu, A., Wang, Y. F., Thorne, R. F., Zhang, X. D., & Wu, M. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0066-7 · Cited by 347
Zhang, J., Yao, T., Wang, Y., Yu, J., Liu, Y., & Lin, Z. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1108496 · Cited by 305
Fox, A. H., & Lamond, A. I. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000687 · Cited by 302
Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer
Ying, L., Huang, Y., Chen, H., Wang, Y., Xia, L., Chen, Y., Liu, Y., & Qiu, F. (2012) · Molecular BioSystems · doi:10.1039/c2mb25386k · Cited by 298
Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers
Takahashi, Y., Sawada, G., Kurashige, J., Uchi, R., Matsumura, T., Ueo, H., Takano, Y., Eguchi, H., Sudo, T., Sugimachi, K., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.698 · Cited by 287
High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng, H.-T., Shi, D.-B., Wang, Y., Li, X.-X., Xu, Y., Tripathi, P., Gu, W.-L., Cai, G.-X., & Cai, S.-J. (2014) · PubMed · Cited by 258
An inducible long noncoding RNA amplifies DNA damage signaling
Schmitt, A. M., Garcia, J. T., Hung, T., Flynn, R. A., Shen, Y., Qu, K., Payumo, A. Y., Peres-da-Silva, A., Broz, D. K., Baum, R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3673 · Cited by 239
Miyagawa, R., Tano, K., Mizuno, R., Nakamura, Y., Ijiri, K., Rakwal, R., Shibato, J., Masuo, Y., Mayeda, A., Hirose, T., et al. (2012) · RNA · doi:10.1261/rna.028639.111 · Cited by 237
Ren, Y., Jia, H.-H., Xu, Y.-Q., Zhou, X., Zhao, X.-H., Wang, Y.-F., Song, X., Zhu, Z.-Y., Sun, T., Dou, Y., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0758-4 · Cited by 217
Chen, C.-L., Tseng, Y.-W., Wu, J.-C., Chen, G.-Y., Lin, K.-C., Hwang, S.-M., & Hu, Y.-C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.023 · Cited by 214
Neat1 is a p53-inducible lincRNA essential for transformation suppression
Mello, S. S., Sinow, C., Raj, N., Mazur, P. K., Bieging-Rolett, K., Broz, D. K., Imam, J. F. C., Vogel, H., Wood, L. D., Sage, J., et al. (2017) · Genes & Development · doi:10.1101/gad.284661.116 · Cited by 202
Terashima, M., Tange, S., Ishimura, A., & Suzuki, T. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.750950 · Cited by 199
Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition
Mitra, R., Chen, X., Greenawalt, E. J., Maulik, U., Jiang, W., Zhao, Z., & Eischen, C. M. (2017) · Nature Communications · doi:10.1038/s41467-017-01781-0 · Cited by 191
PRC 2 is dispensable for HOTAIR ‐mediated transcriptional repression
Portoso, M., Ragazzini, R., Brenčič, Ž., Moiani, A., Michaud, A., Vassilev, I., Wassef, M., Servant, N., Sargueil, B., & Margueron, R. (2017) · The EMBO Journal · doi:10.15252/embj.201695335 · Cited by 186
Jin, Y., Sj, F., Qiu, S., Shao, N., & Jh, Z. (2017) · PubMed · Cited by 185
LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer
Wang, D., Ding, L., Wang, L., Zhao, Y., Sun, Z., Karnes, R. J., Zhang, J., & Huang, H. (2015) · Oncotarget · doi:10.18632/oncotarget.5728 · Cited by 184
Léveillé, N., Melo, C. A., Rooijers, K., Díaz-Lagares, A., Melo, S. A., Korkmaz, G., Lopes, R., Moqadam, F. A., Maia, A. R., Wijchers, P. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7520 · Cited by 183
Zhu, J., Liu, S., Ye, F., Shen, Y., Tie, Y., Zhu, J., Wei, L., Jin, Y., Fu, H., Wu, Y., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139790 · Cited by 170
Battistelli, C., Cicchini, C., Santangelo, L., Tramontano, A., Grassi, L., Gonzalez, F. J., de Nonno, V, Grassi, G., Amicone, L., & Tripodi, M. (2017) · Oncogene · doi:10.1038/onc.2016.260 · Cited by 168
Jadaliha, M., Zong, X., Malakar, P., Ray, T., Singh, D. K., Freier, S. M., Jensen, T., Prasanth, S. G., Karni, R., Ray, P. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9622 · Cited by 162
Benetatos, L., Hatzimichael, E. C., Dasoula, A., Dranitsaris, G., Tsiara, S., Syrrou, M., Georgiou, I. A., & Bourantas, K. L. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.06.019 · Cited by 153
Lu, Y., Li, T., Wei, G., Liu, L., Chen, Q., Xu, L., Zhang, K., Zeng, D., & Liao, R. (2016) · Tumor Biology · doi:10.1007/s13277-015-4773-4 · Cited by 149
NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer
Li, Y., Li, Y., Chen, W., He, F., Tan, Z., Zheng, J., Wang, W., Zhao, Q., & Li, J. (2015) · Oncotarget · doi:10.18632/oncotarget.4737 · Cited by 140
Somatic mosaicism: on the road to cancer
Fernández, L. C., Torres, M., & Real, F. X. (2015) · Nature reviews. Cancer · doi:10.1038/nrc.2015.1 · Cited by 139
Wang, G., Li, Z., Zhao, Q., Zhu, Y., Zhao, C., LI, X., Ma, Z., Li, X., & Zhang, Y. (2014) · Oncology Reports · doi:10.3892/or.2014.3047 · Cited by 138
NEAT1 is Required for Survival of Breast Cancer Cells through FUS and miR-548
Hao, K., Zhao, L., Xu, F., Xu, H., Zou, L., Yang, Q., Su, X., Peng, L., & Jiao, B. (2016) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s29414 · Cited by 132
Latorre, E., Carelli, S., Raimondi, I., D’Agostino, V., Castiglioni, I., Zucal, C., Moro, G. P., Luciani, A., Ghilardi, G., Monti, E., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2018 · Cited by 127
Zhang, M., Wb, W., Zw, W., & Xh, W. (2017) · PubMed · Cited by 121
Zhang, S., Zhang, G., & Liu, J. (2016) · Apmis · doi:10.1111/apm.12555 · Cited by 112
Paradigm shifts in genomics through the FANTOM projects
de Hoon, M., Shin, J. W., & Carninci, P. (2015) · Mammalian Genome · doi:10.1007/s00335-015-9593-8 · Cited by 109
Clinical Significance of Long Intergenic Noncoding RNA-p21 in Colorectal Cancer
Zhai, H., Fesler, A. T., Schee, K., Fodstad, Ø., Flatmark, K., & Ju, J. (2013) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2013.06.003 · Cited by 109
Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152
Zheng, J., Yu, F., Dong, P., Wu, L., Zhang, Y., Hu, Y., & Zheng, L. (2016) · Oncotarget · doi:10.18632/oncotarget.11709 · Cited by 94
Yang, X., Xu, H., Xu, X., Ru, G., Liu, W., Zhu, J., Wu, Y., ZHAO, K., Wu, Y., XING, C.-G., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4397 · Cited by 90
Zhuang, C., Li, J., Liu, Y., Chen, M., Yuan, J., Fu, X., Zhan, Y., Liu, L., Lin, J., Zhou, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5880 · Cited by 81
Zhao, H.-J., Kim, Y., Wang, P.-R., Lapointe, J., Tibshirani, R., Pollack, J., & Brooks, J. (2005) · The Prostate · doi:10.1002/pros.20158 · Cited by 79
Aiello, A., Bacci, L., Re, A., Ripoli, C., Pierconti, F., Pinto, F., Masetti, R., Grassi, C., Gaetano, C., Bassi, P. F., et al. (2016) · Scientific Reports · doi:10.1038/srep38414 · Cited by 79
Ma, J., Wang, P., Yao, Y., Liu, Y., Li, Z., Liu, X., Li, Z., Zhao, X., Xi, Z., Teng, H. W., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.11.008 · Cited by 76
Zhang, Z., Weaver, D. L., Olsen, D., deKay, J., Peng, Z., Ashikaga, T., & Evans, M. F. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203275 · Cited by 73
Wu, B., Jiang, Y., Zhu, F., Sun, D., & He, X. (2017) · Technology in Cancer Research & Treatment · doi:10.1177/1533034617700559 · Cited by 72
Jia, M., Jiang, L., Wang, Y., Huang, J., Yu, M., & Xue, H. (2016) · Hepatology Research · doi:10.1111/hepr.12659 · Cited by 69
Hassanzarei, S., Hashemi, M. M., Sattarifard, H., Hashemi, S. M., Bahari, G., & Ghavami, S. (2017) · Tumor Biology · doi:10.1177/1010428317727539 · Cited by 68
Genome-wide analysis of long noncoding RNA signature in human colorectal cancer
Xue, Y., Ma, G., Gu, D., Zhu, L., Hua, Q., Du, M., Chu, H., Tong, N., Chen, J., Zhang, Z., et al. (2014) · Gene · doi:10.1016/j.gene.2014.11.060 · Cited by 64
Peng, W., Wu, J., & Feng, J. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0396-8 · Cited by 54
Alsibai, K. D., & Meseure, D. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24548 · Cited by 53
NEAT1-containing paraspeckles: Central hubs in stress response and tumor formation
Adriaens, C., & Marine, J. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1235847 · Cited by 39
Meseure, D., Alsibai, K. D., & Nicolas, A. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0158-2 · Cited by 37
Chen, Y., Wei, G., Xia, H., Yu, H., Tang, Q., & Bi, F. (2017) · Oncotarget · doi:10.18632/oncotarget.19130 · Cited by 33
Divergent Activity of the Pseudogene PTENP1 in ER-Positive and Negative Breast Cancer
Yndestad, S., Austreid, E., Skaftnesmo, K. O., Lønning, P. E., & Eikesdal, H. P. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0207 · Cited by 31
Paraspeckles modulate the intranuclear distribution of paraspeckle-associated Ctn RNA
Anantharaman, A., Jadaliha, M., Tripathi, V., Nakagawa, S., Hirose, T., Jantsch, M. F., Prasanth, S. G., & Prasanth, K. V. (2016) · Scientific Reports · doi:10.1038/srep34043 · Cited by 28
Yndestad, S., Austreid, E., Knappskog, S., Chrisanthar, R., Lilleng, P. K., Lønning, P. E., & Eikesdal, H. P. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4160-5 · Cited by 21
p53 partners with RNA in the DNA damage response
Huarte, M. (2016) · Nature Genetics · doi:10.1038/ng.3702 · Cited by 16
p53: It Has It All, But Will It Make It to the Clinic As a Marker in Bladder Cancer?
Real, F. X. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1904 · Cited by 9
ULK1 Can Suppress or Promote Tumor Growth Under Different Conditions
Mao, T., & Liang, O. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805420-8.00012-3 · Cited by 3
Cited by
Akt in cancer: Mediator and more
Revathidevi, S., & Munirajan, A. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.002 · Cited by 691
New insights into the interplay between long non‐coding RNAs and RNA‐binding proteins in cancer
Yao, Z., Yang, Y., Sun, M., He, Y., Liao, L., Chen, K., & Li, B. (2022) · Cancer Communications · doi:10.1002/cac2.12254 · Cited by 288
The function and mechanism of ferroptosis in cancer
Wang, Y., Wei, Z., Pan, K., Li, J., & Chen, Q. (2020) · Apoptosis · doi:10.1007/s10495-020-01638-w · Cited by 263
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
Qu, J., Yan, H., Hou, Y., Cao, W., Liu, Y., Zhang, E., He, J., & Cai, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01224-4 · Cited by 260
Wang, F., Luo, Y., Zhang, L., Younis, M., & Yuan, L. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-021-00309-5 · Cited by 33
Metadata
- Authors
- Sanchez Calle, A., Kawamura, Y., Yamamoto, Y., Takeshita, F., & Ochiya, T.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2018-06-28
- Volume
- 109
- Issue
- 7
- Pages
- 2093-2100
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W2803913659
- Cited by
- 590
- References
- 75
- FWCI
- 21.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.